Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence
Award amount
$1,750,986Program and phase
SBIR · Phase IIAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SURGISENSE CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MF8RGD3WMPK9
- Solicitation number
- PA11-096
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Oxygen Mapping System for Enhanced Colonoscopic Neoplasm Detection
- Device to Improve Treatment of Colorectal Cancer Using O2 Dependent Phosphorescen
- A Device to Reduce Anastomotic Failure in the Treatment of Colorectal Cancer
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
4 SBIR/STTR records share this UEI (2009–2015). Reported award amounts total $4,178,872. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services